ShapeTx
is a Washington-based biotechnology company that develops and commercializes RNA editing therapies for the treatment of cancer and neurodegenerative disorders... Read moreShapeTx
is a Washington-based biotechnology company that develops and commercializes RNA editing therapies for the treatment of cancer and neurodegenerative disorders... Read more
News
Oct 10, 2025
Benzinga
ShapeTx: Shape Therapeutics Shares Breakthrough Preclinical Data for Non-Invasive Treatment of Parkinson's Disease Using a Brain Targeted AAV Gene Therapy at the European Society of Gene & Cell Therapy 32nd Annual Congress
May 16, 2025
StreetInsider
Press Release: ShapeTx : Shape Therapeutics Presents Preclinical Data Highlighting Therapeutic Potential of RNA Editing and AAV Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting
May 07, 2025
The Business Journals: Seattle
ShapeTx: Seattle biotech firm Shape Therapeutics trims workforce
Oct 23, 2024
The Business Journals
ShapeTx: Shape Therapeutics CEO departs, interim named
Oct 17, 2024
Endpoints News
ShapeTx: RNA gene therapy startup Shape hunts for new CEO as Series C awaits
Oct 05, 2024
Pharmabiz
ShapeTx: Shape Therapeutics introduces advances in AIpowered platform for precision RNA editing
May 08, 2024
StreetInsider
Press Release: ShapeTx : Shape Therapeutics RNAfix Editing Platform Achieves >90% Editing in Mouse and Non-Human Primate Brain
Apr 30, 2024
GlobalNewswire
Press Release: ShapeTx : Shape Therapeutics to Showcase RNA Editing in the Brain and Validation of their Stable AAV Producer Cell Line at ASGCT 2024
Nov 30, 2023
Benzinga
ShapeTx: ShapeTX Expands Strategic Collaboration with Roche with Addition of a New Target
Sep 26, 2023
Global Legal Chronicle
ShapeTx: Otsuka's Collaboration with ShapeTX
ShapeTx Competitors
1
2
3
4
5
6